Carmen B Volkart
CIK 1282953 · Global Chief Financial Officer · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.51M
Companies
6
Total Filings
51
Lifetime Open-Market Net
$332.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MODD | Director | 916 | $2.34 | $2.1K | $0 | 19 | 2026-07-02 |
| TCMD | Director | 44,219 | $27.74 | $1.23M | $0 | 5 | 2026-05-08 |
| ANTARES PHARMA, INC. (ATRS) Delisted | Director | — | $5.59 | — | $0 | 1 | 2021-10-29 |
| SONO | Director | 17,029 | $16.80 | $286.1K | $0 | 7 | 2012-02-27 |
| Wright Medical Group N.V. (TRNX) Delisted | Global Chief Financial Officer | 2 | — | — | $332.5K | 2 | 2011-05-13 |
| MEMRY CORP (MRY) Delisted | Director | 21,905 | — | — | $0 | 6 | 2008-04-03 |
Recent Filings · Page 4 of 6
51 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-27 | — | Grant (A) | — | $0 | |
| 2012-04-16 | — | Mixed | −2,500 | -$135.0K | |
| 2012-04-16 | — | Disp (D) | −12,030 | -$649.6K | |
| 2012-02-27 | SONO | U | −2,500 | -$135.0K | EDGAR |
| 2011-05-13 | Wright Medical Group N.V. (TRNX) Delisted | Grant (A) | +9,920 | $0 | EDGAR |
| 2011-04-21 | SONO | Grant (A) | +2,029 | $0 | EDGAR |
| 2011-02-08 | Wright Medical Group N.V. (TRNX) Delisted | Buy (P) | +17,500 | $332.5K | EDGAR |
| 2010-05-17 | — | Grant (A) | +4,550 | $0 | |
| 2010-04-21 | SONO | Grant (A) | +5,000 | $0 | EDGAR |
| 2009-11-16 | — | Grant (A) | +6,790 | $0 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.